Skip to main content

Closed

BEAM: Beam Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+120.0% / yr

Operating margin-226.6%

ROIC-26.2%

Financially safe

Stretched

Debt / equity0.22×

Interest coverage-34.9×

Current ratio16.99×

Beam Therapeutics Inc.

BEAMNASDAQ Global Select·USD·Closed

Beam Therapeutics Inc.

BEAMNASDAQ·USD·Closed

$25.52

−3.66%

$25.52

−$0.97 (3.66%)

52W Range

44thpctl

Volume

0.47×avg

Mkt Cap

2.63BUSD

P/E

-41.4TTM

Div Yield

–ann

52W Range

44thpctl

Volume

0.47×avg

Market Cap

2.63BUSD

P/E Ratio

-41.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings